FDA Inspection 1279225 — Haresh D. Boghara, MD
The FDA completed an inspection of Haresh D. Boghara, MD on August 14, 2025 in Desoto, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 14, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Desoto, TX (United States)
Additional Details
Clinical Investigator (CI)